Coding

Part:BBa_K3142005:Design

Designed by: Luo Xiaolin   Group: iGEM19_SZPT-CHINA   (2019-10-13)
Revision as of 22:09, 20 October 2019 by Xiaolin (Talk | contribs) (→‎References)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Antihypertensive dipeptide（VY）


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.

Source

no

References

Martin, M, A. Wellner, I. Ossowski, and T. Henle. Identification and quantification of inhibitors for Angiotensin-converting enzyme in hypoallergenic infant milk formulas.[J] Agric Food Chem. 2006,56:6333–6338.